PRESS RELEASE published on 06/05/2024 at 07:00, 2 years 1 month ago Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update Valneva announces availability of documentation for its Combined Shareholder Meeting on June 26, 2024, along with corporate update including change in General Counsel & Corporate Secretary. Kendra Wergin appointed as successor Corporate Update Valneva General Counsel Shareholder Meeting Kendra Wergin
BRIEF published on 05/21/2024 at 07:05, 2 years 2 months ago Valneva appoints Dr Hanneke Schuitemaker as Scientific Director Nomination R&D Valneva Vaccines Dr Hanneke Schuitemaker
BRIEF published on 04/12/2024 at 10:42, 2 years 3 months ago Upbeat Valneva Research Update from First Berlin Equity Research Maintains BUY Rating First Berlin Equity Research Buy Recommendation Financial Strategy Valneva Lyme Disease Vaccine
PRESS RELEASE published on 04/12/2024 at 10:37, 2 years 3 months ago Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research reaffirms Buy rating on Valneva with a target price of €8.60, following positive guidance revisions and debt extension First Berlin Equity Research BUY Rating Debt Extension Valneva EUR 8.60
BRIEF published on 02/27/2024 at 16:01, 2 years 5 months ago First Berlin updates its recommendation on Valneva with an adjusted price target First Berlin Equity Research Purchase Recommendation Valneva Simon Scholes Course Objective
PRESS RELEASE published on 02/27/2024 at 16:01, 2 years 5 months ago Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research GmbH updates Valneva SE research report, reiterating Buy recommendation with a target price of €8.60 based on strong FY/23 product revenue recovery and positive outlook for travel vaccines and future prospects Buy Recommendation Research Update Target Price Valneva SE Product Revenue
PRESS RELEASE published on 10/12/2023 at 10:11, 2 years 9 months ago Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 05/22/2023 at 13:41, 3 years 2 months ago Original-Research: Valneva (von First Berlin Equity Research GmbH): Buy
PRESS RELEASE published on 04/04/2023 at 15:46, 3 years 3 months ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
Published on 08/01/2026 at 01:20, 1 day 11 hours ago Gamma Resources Announces $880,000 Private Placement with Full Warrant Coverage
Published on 08/01/2026 at 01:15, 1 day 11 hours ago Clean Air Metals and Fiore-Backed Springbok Ventures Announce Strategic Business Combination
Published on 08/01/2026 at 00:30, 1 day 11 hours ago Battery X Metals Announces Amendment to Corporate Awareness Engagement
Published on 07/31/2026 at 23:20, 1 day 13 hours ago Pentagon I Capital Corp. Announces Conditional Acceptance of Qualifying Transaction with Prospectiva Resources Ltd.
Published on 08/02/2026 at 08:15, 4 hours 7 minutes ago Holcim signs agreement to divest its business in the Philippines
Published on 08/01/2026 at 16:35, 19 hours 47 minutes ago HIZENERGY Enters Global Top Tier with BloombergNEF Tier 1 Listing
Published on 07/31/2026 at 19:55, 1 day 16 hours ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA Reaches Agreement with Financing Partners on Extension of Standstill Agreement and Continuation of Restructuring Process
Published on 07/31/2026 at 19:05, 1 day 17 hours ago Eurobattery Minerals presents the Q2 report for 2026 as the Company accelerates the development of the San Juan tungsten project
Published on 07/31/2026 at 21:00, 1 day 15 hours ago Carrefour completes the sale of its minority stake in CarrefourSA in Turkey to Yeni Mağazacılık A.Ş., operator of the A101 retail chain and controlled by the Aydın Group
Published on 07/31/2026 at 19:13, 1 day 17 hours ago Covivio - Information on Treasury shares transactions between July 29th, 2026 and July 31st, 2026
Published on 07/31/2026 at 18:30, 1 day 17 hours ago Covivio Hotels - 2026 Half-year financial report